Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients
- 1 November 1998
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 31 (8), 647-651
- https://doi.org/10.1016/s0009-9120(98)00077-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosisThe Lancet, 1997
- Effects of Integrelin, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist, in Unstable AnginaCirculation, 1996
- Platelet Glycoprotein IIIaPlAPolymorphism and Myocardial InfarctionNew England Journal of Medicine, 1996
- Platelet glycoprotein IIIa PIA polymorphism in young men with myocardial infarctionThe Lancet, 1996
- A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary ThrombosisNew England Journal of Medicine, 1996
- Cyclic Flow variations after coronary angioplasty in humans: Clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibodyJournal of the American College of Cardiology, 1994
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.JCI Insight, 1989
- The platelet membrane glycoprotein IIb-IIIa complexBlood, 1988